A Win For PainReform Ltd.
Fri, Dec 09, 2022 at 06:58 PM
PainReform Ltd. (PRFX:NASDAQ) soared at $0.53, a gain of 37.2%. On Fri, Dec 09, 2022, PRFX:NASDAQ touched a New 2-Week High of $0.53. The stock appeared on our News Catalysts scanner on Tue, Nov 15, 2022 at 08:38 AM in the 'INVESTOR UPDATE' category. From Mon, Nov 28, 2022, the stock recorded 33.33% Up Days and 40.00% Green Days
About PainReform Ltd. (PRFX:NASDAQ)
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics.
Top 10 Gainers:
- Ambrx Biopharma Inc. American Depositary Shares (each representing seven) (AMAM:NYSE), 1007.59%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 117.57%
- ClearOne, Inc. (CLRO:NASDAQ), 73.4%
- China Jo-Jo Drugstores, Inc. (CJJD:NASDAQ), 53.24%
- Hillstream BioPharma Inc. (HILS:NASDAQ), 43.41%
- Rockley Photonics Holdings Limited (RKLY:NYSE), 40.39%
- Cardiol Therapeutics Inc. (CRDL:NASDAQ), 38.3%
- PainReform Ltd. (PRFX:NASDAQ), 37.21%
- Advanced Human Imaging Limited. (AHI:NASDAQ), 35.97%
- Acer Therapeutics Inc. (ACER:NASDAQ), 35.67%